Skip to main content

Advertisement

SpringerLink
Log in

Update in Addiction Medicine for the Generalist

  • Updates
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.

    Article  PubMed  Google Scholar 

  2. Substance Abuse and Mental Health Services Administration Office of Applied Studies. Results from the 2004 Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration Office of Applied Studies; 2005. DHHS publication no. SMA 05-4062, NSDUH series H-28.

  3. Grant BF, Dawson DA, Stinson FS, et al. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend. 2004;74(3):223–34.

    Article  PubMed  Google Scholar 

  4. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005;352(6):596–607.

    Article  PubMed  CAS  Google Scholar 

  5. Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(7):557–68.

    PubMed  Google Scholar 

  6. Pettinati HM, Weiss RD, Miller WR, Donovan D, Denise B, Rounsaville BJ. COMBINE Monograph Series, Volume 2. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004. DHHS publication no. (NIH) 04-5289.

  7. Anton RF, O’Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA. 2006;295(17):2003–17.

    Article  PubMed  CAS  Google Scholar 

  8. Pettinati HM, Weiss RD, Dundon W, et al. A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J Stud Alcohol Suppl. 2005;(15):170–8.

  9. Miller WR. Combined behavioral intervention manual. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004. NIH publication no. 04-5288.

  10. Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293(13):1617–25.

    Article  PubMed  CAS  Google Scholar 

  11. Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol. 2001;62(2):211–20.

    PubMed  CAS  Google Scholar 

  12. Tucker JA, Roth DL. Extending the evidence hierarchy to enhance evidence-based practice for substance use disorders. Addiction. 2006;101(7):918–32.

    Article  PubMed  Google Scholar 

  13. Agency for Healthcare Research and Quality. The Guide to Clinical Preventive Services, 2005. Recommendations of the U.S. Preventive Services Task Force. Available at http://www.preventiveservices.ahrq.gov. Accessed December 1, 2006.

  14. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45.

    Article  PubMed  Google Scholar 

  15. National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much: A Clinician’s Guide. Rockville, MD: U.S. Department of Health & Human Services; 2005. NIH publication no. 05-3769.

    Google Scholar 

  16. Fleming MF. In search of the Holy Grail for the detection of hazardous drinking. J Fam Pract. 2001;50(4):321–2.

    PubMed  CAS  Google Scholar 

  17. Gordon AJ, Maisto SA, McNeil M, et al. Three questions can detect hazardous drinkers. J Fam Pract. 2001;50(4):313–20.

    PubMed  CAS  Google Scholar 

  18. Canagasaby A, Vinson DC. Screening for hazardous or harmful drinking using one or two quantity–frequency questions. Alcohol Alcohol. 2005;40(3):208–13.

    PubMed  Google Scholar 

  19. Williams R, Vinson DC. Validation of a single screening question for problem drinking. J Fam Pract. 2001;50(4):307–12.

    PubMed  CAS  Google Scholar 

  20. Vinson DC. Screening question for alcohol abuse. Am Fam Physician. 2002;66(2):209.

    PubMed  Google Scholar 

  21. Taj N, Devera-Sales A, Vinson DC. Screening for problem drinking: does a single question work? J Fam Pract. 1998;46(4):328–35.

    PubMed  CAS  Google Scholar 

  22. National Center For Chronic Disease Prevention and Health Promotion, Center for Disease Control. Percentage of adults who were current, former, or never smokers, overall and by sex, race, Hispanic origin, age, and education, National Health Interview Surveys, selected years—United States, 1965–2000. Available at: http://www.cdc.gov/tobacco/research_data/adults_prev/adstat1print.htm. Accessed October 5, 2006.

  23. Centers for Disease Control and Prevention. Smoking-attributable mortality and years of potential life lost—United States, 1984. MMWR Morb Mortal Wkly Rep. 1997;46(20):444–51.

    Google Scholar 

  24. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2004;(1):CD003041.

  25. Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology. 1993;4(4):295–302.

    Article  PubMed  CAS  Google Scholar 

  26. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84.

    Article  PubMed  CAS  Google Scholar 

  27. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22.

    Article  Google Scholar 

  28. National Cholesterol Education Program Expert Panel on Detection EaToHBCiAATPI. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.

    Google Scholar 

  29. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827–38.

    Article  PubMed  CAS  Google Scholar 

  30. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227–39.

    Article  PubMed  Google Scholar 

  31. The Tobacco Use and Dependence Clinical Practice Guideline Panel SaCR. A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report. JAMA. 2000;283(24):3244–54.

    Article  Google Scholar 

  32. Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA. 1998;279(8):604–8.

    Article  PubMed  CAS  Google Scholar 

  33. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47–55.

    Article  PubMed  CAS  Google Scholar 

  34. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56–63.

    Article  PubMed  CAS  Google Scholar 

  35. Tonstad S, Tonnesen P, Hajek P, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):64–71.

    Article  PubMed  CAS  Google Scholar 

  36. Johnston LD, O’Malley PM, Backman JG, Schulenberg JE. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings. Bethesda, MD: National Institute on Drug Abuse; 2005.

    Google Scholar 

  37. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35(12):1747–59.

    Article  PubMed  Google Scholar 

  38. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage. 2004;28(2):176–88.

    Article  PubMed  Google Scholar 

  39. Turner BJ, Laine C, Lin YT, Lynch K. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. Arch Intern Med. 2005;165(15):1769–76.

    Article  PubMed  Google Scholar 

  40. Institute of Medicine. Improving the Quality of Healthcare for Mental and Substance-use Conditions: The Quality Chasm Series. Washington, DC: The National Academies Press; 2005.

    Google Scholar 

  41. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: The National Academies Press; 2001.

    Google Scholar 

Download references

Acknowledgements

All authors are members of the Society of General Internal Medicine’s Substance Abuse Task Force to which we are deeply indebted for its support. The authors also wish to thank Kara Mays for her contributions of coordinating the review and editing this paper.

Potential Financial Conflicts of Interest

Dr. Gourevitch reported receiving a grant from Cephalon, regarding use of depot naltrexone (Vivitrol) for treatment of alcohol dependence. The other authors reported no conflicts of interest.

Author information

Authors and Affiliations

  1. Mental Illness Research, Education, and Clinical, Center, University of Pittsburgh, Pittsburgh, PA, USA

    Adam J. Gordon MD, MPH

  2. Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Mailcode 151-C, University Drive C, Pittsburgh, PA, 15240, USA

    Adam J. Gordon MD, MPH

  3. Center for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA

    Adam J. Gordon MD, MPH

  4. Yale University School of Medicine, New Haven, CT, USA

    Lynn E. Sullivan MD & David A. Fiellin MD

  5. Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA

    Daniel P. Alford MD, MPH & Jeffrey H. Samet MD, MA, MPH

  6. Albert Einstein College of Medicine and Montefiore Medical Center, New York, NY, USA

    Julia H. Arnsten MD, MPH & Hillary V. Kunins MD, MPH, MS

  7. New York University School of Medicine, New York, NY, USA

    Marc N. Gourevitch MD, MPH

  8. University of Alabama at Birmingham School of Medicine, and the Deep South Center on Effectiveness, Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA

    Stefan G. Kertesz MD, MSc

  9. University of Washington School of Medicine, Seattle, WA, USA

    Joseph O. Merrill MD

Authors
  1. Adam J. Gordon MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lynn E. Sullivan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel P. Alford MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julia H. Arnsten MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marc N. Gourevitch MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stefan G. Kertesz MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hillary V. Kunins MD, MPH, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Joseph O. Merrill MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jeffrey H. Samet MD, MA, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. David A. Fiellin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam J. Gordon MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordon, A.J., Sullivan, L.E., Alford, D.P. et al. Update in Addiction Medicine for the Generalist. J GEN INTERN MED 22, 1190–1194 (2007). https://doi.org/10.1007/s11606-007-0133-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-007-0133-4

KEY WORDS

Search

Navigation